Halozyme Therapeutics News
Baxter Receives Marketing Authorization for HyQvia in European Union
Business Wire May 21Baxter International Inc. and Halozyme Therapeutics, Inc., today announced that the European Commission has granted Baxter marketing authorization in all E
Why Halozyme Therapeutics Shares Soared
Fool May 16An upcoming presentation at the American Society of Clinical Oncology excites Halozyme shareholders.
Streetinsider.com's Hot Lunchtime Reads 05/16: (DDD) (BP) (NTAP) (HES)
Street Insider May 16Wedbush Sees No Need to Own Halozyme (HALO)
Street Insider May 16Halozyme To Present New Data On PEGPH20 In Pancreatic Cancer At American Society of Clinical Oncology Annual Meeting
PR Newswire May 15SAN DIEGO, May 15, 2013 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that clinical data from a Phase 1b trial of PEGPH20 (PEGylated Recombinant Human Hyaluronidase), an investigational ...
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| HALO | 7.59 | +0.02 | +0.26% | 858.04M |
New watchlist
